Aimee K. Johnson

Cognitive Hypnotherapy for Pain Management

Pain is a serious health care problem and there is growing evidence to support the use of hypnosis and cognitive-behavioral interventions for pain management. This article reviews clinical techniques and methods of cognitive hypnotherapy for pain management. Current research with emphasis given to randomized, controlled trials is presented and the efficacy of hypnotherapy for pain management is discussed. Evidence for cognitive hypnotherapy in the treatment in chronic pain, cancer, osteoarthritis, sickle cell disease, temporomandibular disorder, fibromyalgia, non-cardiac chest pain, and disability related chronic pains are identified. Implications for clinical practice and research are discussed in light of the accumulating evidence in support of the efficacy and effectiveness of cognitive hypnotherapy for pain management.

Risk factors, pathophysiology, and treatment of hot flashes in cancer.

Answer questions and earn CME/CNE

Hypnosis for Acute Procedural Pain: A Critical Review

Abstract Clinical evidence for the effectiveness of hypnosis in the treatment of acute procedural pain was critically evaluated based on reports from randomized controlled clinical trials (RCTs). Results from the 29 RCTs meeting inclusion criteria suggest that hypnosis decreases pain compared to standard care and attention control groups and that it is at least as effective as comparable adjunct psychological or behavioral therapies. In addition, applying hypnosis in multiple sessions prior to the day of the procedure produced the highest percentage of significant results. Hypnosis was most effective in minor surgical procedures. However, interpretations are limited by considerable risk of bias. Further studies using minimally effective control conditions and systematic control of intervention dose and timing are required to strengthen conclusions.

P02.30. Assessment of hypnotizability in clincal research: development, reliability, and validation of the Elkins Hynotizability Scale

Purpose Hypnotherapy has been shown to be an effective treatment for some conditions such as pain, anxiety, chemotherapy side effects, and hot flashes. Measurement of hypnotizability is essential for research. There are a number of scales that have been developed to measure hypnotizbility in clincal research. However, the currently available scales suffer from a number of important shortcomings such as time for administration, validity concerns, and item difficulty. As a result, hypnotizability is rarely measured in clinical work and research has been limited. The purpose of this study was to develop a new scale to measure hypnotizability that met the following criteria: (1) administration in 30 minutes or less; (2) correlation of .80 or better with the Stanford Hypnotic Susceptibility Scale; and (3) improved item selection.

Hypnosis for hot flashes among postmenopausal women study: A study protocol of an ongoing randomized clinical trial

BackgroundHot flashes are a highly prevalent problem associated with menopause and breast cancer treatments. The recent findings from the Womens Health Initiative have important implications for the significance of a non-hormonal, mind-body intervention for hot flashes in breast cancer survivors. Women who take hormone therapy long-term may have a 1.2 to 2.0 fold increased risk of developing breast cancer. In addition, it is now known that hormone therapy with estrogen and progestin is associated with increased risk of cardiovascular disease and stroke. Currently there are limited options to hormone replacement therapy as non-hormonal pharmacological agents are associated with only modest activity and many adverse side effects. Because of this there is a need for more alternative, non-hormonal therapies. Hypnosis is a mind-body intervention that has been shown to reduce self-reported hot flashes by up to 68% among breast cancer survivors, however, the use of hypnosis for hot flashes among post-menopausal women has not been adequately explored and the efficacy of hypnosis in reducing physiologically measured hot flashes has not yet been determined.Methods/designA sample of 180 post-menopausal women will be randomly assigned to either a 5-session Hypnosis Intervention or 5-session structured-attention control with 12 week follow-up. The present study will compare hypnosis to a structured-attention control in reducing hot flashes (perceived and physiologically monitored) in post-menopausal women in a randomized clinical trial. Outcomes will be hot flashes (self-report daily diaries; physiological monitoring; Hot Flash Related Daily Interference Scale), anxiety (State-Trait Anxiety Inventory; Hospital Anxiety and Depression Scale (HADS); anxiety visual analog scale (VAS rating); depression (Center for Epidemiologic Studies Depression Scale), sexual functioning (Sexual Activity Questionnaire), sleep quality (Pittsburgh Sleep Quality Index) and cortisol.DiscussionThis study will be the first full scale test of hypnosis for hot flashes; one of the first studies to examine both perceived impact and physiologically measured impact of a mind-body intervention for hot flashes using state-of-the-art 24 hour ambulatory physiological monitoring; the first study to examine the effect of hypnosis for hot flashes on cortisol; and the first investigation of the role of cognitive expectancies in treatment of hot flashes in comparison to a Structured-Attention Control.Trial RegistrationThis clinical trial has been registered with ClinicalTrials.gov, a service of the U.S. National Institutes of Health, ClinicalTrials.gov Identifier: NCT01293695.

Memory Decline in Peri- and Post-menopausal Women: The Potential of Mind–Body Medicine to Improve Cognitive Performance

Cognitive decline is a frequent complaint during the menopause transition and among post-menopausal women. Changes in memory correspond with diminished estrogen production. Further, many peri- and post-menopausal women report sleep concerns, depression, and hot flashes, and these factors may contribute to cognitive decline. Hormone therapy can increase estrogen but is contraindicated for many women. Mind–body medicine has been shown to have beneficial effects on sleep, mood, and hot flashes, among post-menopausal women. Further, mind–body medicine holds potential in addressing symptoms of cognitive decline post-menopause. This study proposes an initial framework for how mind–body interventions may improve cognitive performance and inform future research seeking to identify the common and specific factors associated with mind–body medicine for addressing memory decline in peri- and post-menopausal women. It is our hope that this article will eventually lead to a more holistic and integrative approach to the treatment of cognitive deficits in peri- and post-menopausal women.

Medical hypnosis for pain and psychological distress during burn wound debridement: a critical review

Introduction Burn injuries are often considered to be one of the most physically and psychologically damaging experiences an individual may endure. Because of this, more treatment options for managing pain and distress during burn wound debridement are needed. When used in combination with traditional treatment, medical hypnosis may offer health-care professionals an option for meeting the needs of patients with burn wounds. This article offers a critical review of the literature currently available on the efficacy of medical hypnosis for managing pain and distress during wound debridement and offers suggestions for an improved methodology for future trials. Materials and Methods MEDLINE, PsycINFO, Psyc ARTICLES, HealthSource: Nursing Edition, PubMed and Google Scholar were searched using the keywords ‘hypnosis’, ‘burn wounds’, ‘pain’ and ‘debridement’. Additional articles were selected from the bibliographies of representative literature. All experimental and quasi- experimental studies investigating the efficacy of hypnosis for managing pain and psychological distress during wound debridement were included in our results. Results Six studies involving a total of 217 participants met our inclusion criteria. The results of these studies suggest that hypnosis may be more effective than structured attention for reducing patients’ pain and anxiety levels during wound debridement. However, results are inconclusive due to oversights in study design, and additional studies that correct these design flaws are needed. Conclusion The existing evidence suggests that medical hypnosis may be effective in managing pain and distress for burn victims who have difficulty coping during wound debridement. Further investigation is warranted.

Hypnotic Relaxation Therapy and Sexual Function in PostmenopausalWomen: Results of a Randomized Clinical Trial

Abstract Sexual dysfunction is a common problem for postmenopausal women. This study, as part of a larger randomized controlled trial, examined the effect of hypnotic relaxation therapy on sexual dysfunction, a secondary study outcome, in postmenopausal women. Sexual function was assessed using the Sexual Activity Questionnaire (SAQ). Significant improvement in sexual pleasure and discomfort were reported following 5 weekly sessions of hypnotic relaxation therapy, compared with those receiving an attention control. Total SAQ scores showed significant improvement in the hypnotic relaxation therapy treatment group while holding baseline SAQ scores constant. Improvements showed a slight increase at the Week 12 follow-up. The results of this analysis provide initial support for the use of hypnotic relaxation therapy to improve sexual function in postmenopausal women.

Factor Analysis of the Elkins Hypnotizability Scale

Abstract Assessment of hypnotizability can provide important information for hypnosis research and practice. The Elkins Hypnotizability Scale (EHS) consists of 12 items and was developed to provide a time-efficient measure for use in both clinical and laboratory settings. The EHS has been shown to be a reliable measure with support for convergent validity with the Stanford Hypnotic Susceptibility Scale, Form C (r = .821, p < .001). The current study examined the factor structure of the EHS, which was administered to 252 adults (51.3% male; 48.7% female). Average time of administration was 25.8 minutes. Four factors selected on the basis of the best theoretical fit accounted for 63.37% of the variance. The results of this study provide an initial factor structure for the EHS.

OA14.05. Hypnosis for hot flashes: results from a randomized clinical trial and future directions

Purpose Hot flashes are a significant clinical problem for many women. Currently there are limited options to hormone replacement therapy as non-hormonal pharmacological agents are associated with only modest activity and many adverse side effects. Hypnosis is one mind-body therapy that seems particularly promising for treating hot flashes and was investigated in the present study. This study examined the efficacy of hypnosis in reducing both self-reported and physiologically determined hot flash frequency and severity among post-menopausal women.